3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Histiocytosis
1
Head and Neck Neoplasms
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Immunotherapy
×
Clear all
No trials found.